nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—ABCB1—Mitomycin—urinary bladder cancer	0.281	0.379	CbGbCtD
Fluticasone furoate—CYP3A4—Thiotepa—urinary bladder cancer	0.128	0.172	CbGbCtD
Fluticasone furoate—ABCB1—Gemcitabine—urinary bladder cancer	0.0809	0.109	CbGbCtD
Fluticasone furoate—ABCB1—Cisplatin—urinary bladder cancer	0.0588	0.0792	CbGbCtD
Fluticasone furoate—ABCB1—Etoposide—urinary bladder cancer	0.0577	0.0779	CbGbCtD
Fluticasone furoate—ABCB1—Doxorubicin—urinary bladder cancer	0.0394	0.0531	CbGbCtD
Fluticasone furoate—ABCB1—Methotrexate—urinary bladder cancer	0.0381	0.0514	CbGbCtD
Fluticasone furoate—CYP3A4—Etoposide—urinary bladder cancer	0.0346	0.0466	CbGbCtD
Fluticasone furoate—CYP3A4—Doxorubicin—urinary bladder cancer	0.0236	0.0318	CbGbCtD
Fluticasone furoate—Nasal irritation—Fluorouracil—urinary bladder cancer	0.0107	0.0589	CcSEcCtD
Fluticasone furoate—Growth retardation—Thiotepa—urinary bladder cancer	0.00992	0.0544	CcSEcCtD
Fluticasone furoate—Nasal discomfort—Fluorouracil—urinary bladder cancer	0.00652	0.0358	CcSEcCtD
Fluticasone furoate—NR3C1—urine—urinary bladder cancer	0.0055	0.19	CbGeAlD
Fluticasone furoate—Ulcer—Mitomycin—urinary bladder cancer	0.00473	0.026	CcSEcCtD
Fluticasone furoate—CYP3A4—urine—urinary bladder cancer	0.00416	0.144	CbGeAlD
Fluticasone furoate—ABCB1—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.0041	0.0868	CbGpPWpGaD
Fluticasone furoate—Back pain—Valrubicin—urinary bladder cancer	0.00275	0.0151	CcSEcCtD
Fluticasone furoate—NR3C1—Endoderm Differentiation—BPTF—urinary bladder cancer	0.00262	0.0555	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00253	0.0535	CbGpPWpGaD
Fluticasone furoate—Cataract—Thiotepa—urinary bladder cancer	0.00237	0.013	CcSEcCtD
Fluticasone furoate—Impaired healing—Methotrexate—urinary bladder cancer	0.00224	0.0123	CcSEcCtD
Fluticasone furoate—Infection—Carboplatin—urinary bladder cancer	0.00213	0.0117	CcSEcCtD
Fluticasone furoate—Herpes simplex—Fluorouracil—urinary bladder cancer	0.00202	0.0111	CcSEcCtD
Fluticasone furoate—Ulcer—Gemcitabine—urinary bladder cancer	0.002	0.011	CcSEcCtD
Fluticasone furoate—NR3C1—prostate gland—urinary bladder cancer	0.00197	0.0683	CbGeAlD
Fluticasone furoate—Ulcer—Fluorouracil—urinary bladder cancer	0.00197	0.0108	CcSEcCtD
Fluticasone furoate—Ulcer—Cisplatin—urinary bladder cancer	0.00187	0.0102	CcSEcCtD
Fluticasone furoate—Body temperature increased—Valrubicin—urinary bladder cancer	0.00183	0.0101	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Epirubicin—urinary bladder cancer	0.0018	0.00986	CcSEcCtD
Fluticasone furoate—NR3C1—Signaling events mediated by HDAC Class II—HDAC4—urinary bladder cancer	0.00174	0.0367	CbGpPWpGaD
Fluticasone furoate—Vulvovaginal candidiasis—Epirubicin—urinary bladder cancer	0.00172	0.00947	CcSEcCtD
Fluticasone furoate—Ulcer—Etoposide—urinary bladder cancer	0.00171	0.00939	CcSEcCtD
Fluticasone furoate—Cough—Mitomycin—urinary bladder cancer	0.00171	0.00938	CcSEcCtD
Fluticasone furoate—Body temperature increased—Carboplatin—urinary bladder cancer	0.0017	0.00932	CcSEcCtD
Fluticasone furoate—NR3C1—seminal vesicle—urinary bladder cancer	0.00167	0.0577	CbGeAlD
Fluticasone furoate—Vaginal moniliasis—Doxorubicin—urinary bladder cancer	0.00166	0.00913	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Epirubicin—urinary bladder cancer	0.00166	0.0091	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Doxorubicin—urinary bladder cancer	0.0016	0.00876	CcSEcCtD
Fluticasone furoate—Diarrhoea—Valrubicin—urinary bladder cancer	0.00159	0.00871	CcSEcCtD
Fluticasone furoate—Candida infection—Etoposide—urinary bladder cancer	0.00154	0.00848	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Doxorubicin—urinary bladder cancer	0.00153	0.00842	CcSEcCtD
Fluticasone furoate—Dizziness—Valrubicin—urinary bladder cancer	0.00153	0.00842	CcSEcCtD
Fluticasone furoate—Rash—Valrubicin—urinary bladder cancer	0.00146	0.00803	CcSEcCtD
Fluticasone furoate—Dermatitis—Valrubicin—urinary bladder cancer	0.00146	0.00802	CcSEcCtD
Fluticasone furoate—Headache—Valrubicin—urinary bladder cancer	0.00145	0.00797	CcSEcCtD
Fluticasone furoate—NR3C1—epithelium—urinary bladder cancer	0.00145	0.0502	CbGeAlD
Fluticasone furoate—Dyspnoea—Mitomycin—urinary bladder cancer	0.00142	0.00782	CcSEcCtD
Fluticasone furoate—NR3C1—smooth muscle tissue—urinary bladder cancer	0.0014	0.0483	CbGeAlD
Fluticasone furoate—Nausea—Valrubicin—urinary bladder cancer	0.00138	0.00756	CcSEcCtD
Fluticasone furoate—NR3C1—renal system—urinary bladder cancer	0.00135	0.0465	CbGeAlD
Fluticasone furoate—NR3C1—urethra—urinary bladder cancer	0.00132	0.0457	CbGeAlD
Fluticasone furoate—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00132	0.028	CbGpPWpGaD
Fluticasone furoate—Body temperature increased—Mitomycin—urinary bladder cancer	0.00126	0.00693	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Thiotepa—urinary bladder cancer	0.00122	0.00672	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Fluorouracil—urinary bladder cancer	0.00121	0.00664	CcSEcCtD
Fluticasone furoate—Epistaxis—Thiotepa—urinary bladder cancer	0.00119	0.00652	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—KRT5—urinary bladder cancer	0.00119	0.0251	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.00117	0.0247	CbGpPWpGaD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00116	0.0246	CbGpPWpGaD
Fluticasone furoate—Nasopharyngitis—Cisplatin—urinary bladder cancer	0.00115	0.00629	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Thiotepa—urinary bladder cancer	0.00111	0.0061	CcSEcCtD
Fluticasone furoate—Dysphonia—Epirubicin—urinary bladder cancer	0.0011	0.00605	CcSEcCtD
Fluticasone furoate—Diarrhoea—Mitomycin—urinary bladder cancer	0.00109	0.006	CcSEcCtD
Fluticasone furoate—NR3C1—female reproductive system—urinary bladder cancer	0.00108	0.0373	CbGeAlD
Fluticasone furoate—ABCB1—prostate gland—urinary bladder cancer	0.00106	0.0365	CbGeAlD
Fluticasone furoate—Eye disorder—Thiotepa—urinary bladder cancer	0.00106	0.0058	CcSEcCtD
Fluticasone furoate—Dizziness—Mitomycin—urinary bladder cancer	0.00106	0.0058	CcSEcCtD
Fluticasone furoate—Herpes simplex—Methotrexate—urinary bladder cancer	0.00105	0.00577	CcSEcCtD
Fluticasone furoate—Ulcer—Methotrexate—urinary bladder cancer	0.00102	0.00562	CcSEcCtD
Fluticasone furoate—Immune system disorder—Thiotepa—urinary bladder cancer	0.00102	0.00561	CcSEcCtD
Fluticasone furoate—Dysphonia—Doxorubicin—urinary bladder cancer	0.00102	0.0056	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00102	0.00559	CcSEcCtD
Fluticasone furoate—CYP3A4—renal system—urinary bladder cancer	0.00102	0.0352	CbGeAlD
Fluticasone furoate—Conjunctivitis—Fluorouracil—urinary bladder cancer	0.00101	0.00556	CcSEcCtD
Fluticasone furoate—Rash—Mitomycin—urinary bladder cancer	0.00101	0.00553	CcSEcCtD
Fluticasone furoate—Dermatitis—Mitomycin—urinary bladder cancer	0.00101	0.00552	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.001	0.0212	CbGpPWpGaD
Fluticasone furoate—Headache—Mitomycin—urinary bladder cancer	0.001	0.00549	CcSEcCtD
Fluticasone furoate—Herpes simplex—Epirubicin—urinary bladder cancer	0.000984	0.0054	CcSEcCtD
Fluticasone furoate—Epistaxis—Fluorouracil—urinary bladder cancer	0.000983	0.00539	CcSEcCtD
Fluticasone furoate—NR3C1—vagina—urinary bladder cancer	0.000975	0.0337	CbGeAlD
Fluticasone furoate—Conjunctivitis—Cisplatin—urinary bladder cancer	0.00096	0.00527	CcSEcCtD
Fluticasone furoate—Ulcer—Epirubicin—urinary bladder cancer	0.000959	0.00526	CcSEcCtD
Fluticasone furoate—Back pain—Thiotepa—urinary bladder cancer	0.000952	0.00523	CcSEcCtD
Fluticasone furoate—Nausea—Mitomycin—urinary bladder cancer	0.000949	0.00521	CcSEcCtD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000947	0.02	CbGpPWpGaD
Fluticasone furoate—Pharyngitis—Gemcitabine—urinary bladder cancer	0.000944	0.00518	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.000935	0.00513	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Epirubicin—urinary bladder cancer	0.000935	0.00513	CcSEcCtD
Fluticasone furoate—Pharyngitis—Fluorouracil—urinary bladder cancer	0.000928	0.0051	CcSEcCtD
Fluticasone furoate—Herpes simplex—Doxorubicin—urinary bladder cancer	0.00091	0.005	CcSEcCtD
Fluticasone furoate—Agitation—Thiotepa—urinary bladder cancer	0.000905	0.00497	CcSEcCtD
Fluticasone furoate—ABCB1—seminal vesicle—urinary bladder cancer	0.000894	0.0309	CbGeAlD
Fluticasone furoate—Ulcer—Doxorubicin—urinary bladder cancer	0.000887	0.00487	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.000871	0.00478	CcSEcCtD
Fluticasone furoate—Candida infection—Epirubicin—urinary bladder cancer	0.000866	0.00475	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.000865	0.00475	CcSEcCtD
Fluticasone furoate—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000859	0.00472	CcSEcCtD
Fluticasone furoate—Cough—Thiotepa—urinary bladder cancer	0.000859	0.00472	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.000857	0.00471	CcSEcCtD
Fluticasone furoate—Visual impairment—Cisplatin—urinary bladder cancer	0.000854	0.00469	CcSEcCtD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.00085	0.018	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptors—ESR2—urinary bladder cancer	0.000841	0.0178	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000832	0.0176	CbGpPWpGaD
Fluticasone furoate—Eye disorder—Cisplatin—urinary bladder cancer	0.000829	0.00455	CcSEcCtD
Fluticasone furoate—CYP3A4—female reproductive system—urinary bladder cancer	0.000815	0.0282	CbGeAlD
Fluticasone furoate—Back pain—Gemcitabine—urinary bladder cancer	0.000801	0.0044	CcSEcCtD
Fluticasone furoate—Candida infection—Doxorubicin—urinary bladder cancer	0.000801	0.0044	CcSEcCtD
Fluticasone furoate—Immune system disorder—Cisplatin—urinary bladder cancer	0.000801	0.0044	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.000799	0.00439	CcSEcCtD
Fluticasone furoate—Infection—Thiotepa—urinary bladder cancer	0.000798	0.00438	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000788	0.00432	CcSEcCtD
Fluticasone furoate—ABCB1—epithelium—urinary bladder cancer	0.000777	0.0269	CbGeAlD
Fluticasone furoate—Eye disorder—Etoposide—urinary bladder cancer	0.000759	0.00417	CcSEcCtD
Fluticasone furoate—Visual disturbance—Methotrexate—urinary bladder cancer	0.000742	0.00407	CcSEcCtD
Fluticasone furoate—Immune system disorder—Etoposide—urinary bladder cancer	0.000734	0.00403	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Etoposide—urinary bladder cancer	0.000732	0.00402	CcSEcCtD
Fluticasone furoate—Tremor—Cisplatin—urinary bladder cancer	0.000723	0.00397	CcSEcCtD
Fluticasone furoate—Cough—Gemcitabine—urinary bladder cancer	0.000723	0.00397	CcSEcCtD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—urinary bladder cancer	0.000721	0.0153	CbGpPWpGaD
Fluticasone furoate—ABCB1—renal system—urinary bladder cancer	0.00072	0.0249	CbGeAlD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000715	0.0151	CbGpPWpGaD
Fluticasone furoate—ABCB1—urethra—urinary bladder cancer	0.000708	0.0245	CbGeAlD
Fluticasone furoate—Back pain—Etoposide—urinary bladder cancer	0.000684	0.00375	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000676	0.00371	CcSEcCtD
Fluticasone furoate—Infection—Gemcitabine—urinary bladder cancer	0.000671	0.00369	CcSEcCtD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.000665	0.0141	CbGpPWpGaD
Fluticasone furoate—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000665	0.00365	CcSEcCtD
Fluticasone furoate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—urinary bladder cancer	0.000664	0.014	CbGpPWpGaD
Fluticasone furoate—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000663	0.00364	CcSEcCtD
Fluticasone furoate—Infection—Fluorouracil—urinary bladder cancer	0.00066	0.00362	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000652	0.00358	CcSEcCtD
Fluticasone furoate—Migraine—Epirubicin—urinary bladder cancer	0.000648	0.00356	CcSEcCtD
Fluticasone furoate—Urticaria—Thiotepa—urinary bladder cancer	0.000638	0.0035	CcSEcCtD
Fluticasone furoate—Body temperature increased—Thiotepa—urinary bladder cancer	0.000635	0.00349	CcSEcCtD
Fluticasone furoate—NR3C1—lymph node—urinary bladder cancer	0.000631	0.0218	CbGeAlD
Fluticasone furoate—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00063	0.00346	CcSEcCtD
Fluticasone furoate—Infection—Cisplatin—urinary bladder cancer	0.000626	0.00344	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000618	0.00339	CcSEcCtD
Fluticasone furoate—Cough—Etoposide—urinary bladder cancer	0.000617	0.00339	CcSEcCtD
Fluticasone furoate—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000603	0.00331	CcSEcCtD
Fluticasone furoate—Migraine—Doxorubicin—urinary bladder cancer	0.000599	0.00329	CcSEcCtD
Fluticasone furoate—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000595	0.0126	CbGpPWpGaD
Fluticasone furoate—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000592	0.00325	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000592	0.00325	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000589	0.00323	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000577	0.00317	CcSEcCtD
Fluticasone furoate—ABCB1—female reproductive system—urinary bladder cancer	0.000577	0.0199	CbGeAlD
Fluticasone furoate—Infection—Etoposide—urinary bladder cancer	0.000573	0.00315	CcSEcCtD
Fluticasone furoate—Dyspnoea—Cisplatin—urinary bladder cancer	0.000562	0.00308	CcSEcCtD
Fluticasone furoate—Diarrhoea—Thiotepa—urinary bladder cancer	0.00055	0.00302	CcSEcCtD
Fluticasone furoate—Bronchitis—Epirubicin—urinary bladder cancer	0.000547	0.003	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000545	0.00299	CcSEcCtD
Fluticasone furoate—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000534	0.00293	CcSEcCtD
Fluticasone furoate—Dizziness—Thiotepa—urinary bladder cancer	0.000531	0.00292	CcSEcCtD
Fluticasone furoate—Urticaria—Fluorouracil—urinary bladder cancer	0.000528	0.0029	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000527	0.00289	CcSEcCtD
Fluticasone furoate—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000525	0.00288	CcSEcCtD
Fluticasone furoate—ABCB1—vagina—urinary bladder cancer	0.000522	0.018	CbGeAlD
Fluticasone furoate—Dyspnoea—Etoposide—urinary bladder cancer	0.000515	0.00282	CcSEcCtD
Fluticasone furoate—Epistaxis—Methotrexate—urinary bladder cancer	0.000511	0.00281	CcSEcCtD
Fluticasone furoate—NR3C1—Nuclear Receptors—ESR1—urinary bladder cancer	0.00051	0.0108	CbGpPWpGaD
Fluticasone furoate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—urinary bladder cancer	0.00051	0.0108	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.00051	0.0108	CbGpPWpGaD
Fluticasone furoate—Rash—Thiotepa—urinary bladder cancer	0.000507	0.00278	CcSEcCtD
Fluticasone furoate—Bronchitis—Doxorubicin—urinary bladder cancer	0.000506	0.00278	CcSEcCtD
Fluticasone furoate—Dermatitis—Thiotepa—urinary bladder cancer	0.000506	0.00278	CcSEcCtD
Fluticasone furoate—Headache—Thiotepa—urinary bladder cancer	0.000503	0.00276	CcSEcCtD
Fluticasone furoate—Body temperature increased—Cisplatin—urinary bladder cancer	0.000498	0.00273	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000493	0.00271	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00049	0.00269	CcSEcCtD
Fluticasone furoate—NR3C1—Circadian Clock—NCOR1—urinary bladder cancer	0.000483	0.0102	CbGpPWpGaD
Fluticasone furoate—Pharyngitis—Methotrexate—urinary bladder cancer	0.000483	0.00265	CcSEcCtD
Fluticasone furoate—Epistaxis—Epirubicin—urinary bladder cancer	0.000478	0.00263	CcSEcCtD
Fluticasone furoate—Nausea—Thiotepa—urinary bladder cancer	0.000477	0.00262	CcSEcCtD
Fluticasone furoate—Visual impairment—Methotrexate—urinary bladder cancer	0.000469	0.00257	CcSEcCtD
Fluticasone furoate—NR3C1—Nuclear Receptors—PPARG—urinary bladder cancer	0.000466	0.00985	CbGpPWpGaD
Fluticasone furoate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000464	0.00255	CcSEcCtD
Fluticasone furoate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000462	0.00254	CcSEcCtD
Fluticasone furoate—Urticaria—Etoposide—urinary bladder cancer	0.000458	0.00252	CcSEcCtD
Fluticasone furoate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—urinary bladder cancer	0.000457	0.00967	CbGpPWpGaD
Fluticasone furoate—Body temperature increased—Etoposide—urinary bladder cancer	0.000456	0.0025	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000456	0.0025	CcSEcCtD
Fluticasone furoate—Eye disorder—Methotrexate—urinary bladder cancer	0.000455	0.0025	CcSEcCtD
Fluticasone furoate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000455	0.0025	CcSEcCtD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000454	0.00961	CbGpPWpGaD
Fluticasone furoate—Pharyngitis—Epirubicin—urinary bladder cancer	0.000452	0.00248	CcSEcCtD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000448	0.00948	CbGpPWpGaD
Fluticasone furoate—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000447	0.00246	CcSEcCtD
Fluticasone furoate—Epistaxis—Doxorubicin—urinary bladder cancer	0.000443	0.00243	CcSEcCtD
Fluticasone furoate—Immune system disorder—Methotrexate—urinary bladder cancer	0.000439	0.00241	CcSEcCtD
Fluticasone furoate—Dizziness—Fluorouracil—urinary bladder cancer	0.000439	0.00241	CcSEcCtD
Fluticasone furoate—Visual impairment—Epirubicin—urinary bladder cancer	0.000439	0.00241	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000439	0.00241	CcSEcCtD
Fluticasone furoate—Diarrhoea—Cisplatin—urinary bladder cancer	0.000431	0.00237	CcSEcCtD
Fluticasone furoate—Rash—Gemcitabine—urinary bladder cancer	0.000426	0.00234	CcSEcCtD
Fluticasone furoate—Dermatitis—Gemcitabine—urinary bladder cancer	0.000426	0.00234	CcSEcCtD
Fluticasone furoate—Eye disorder—Epirubicin—urinary bladder cancer	0.000426	0.00234	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000425	0.00233	CcSEcCtD
Fluticasone furoate—Headache—Gemcitabine—urinary bladder cancer	0.000423	0.00232	CcSEcCtD
Fluticasone furoate—Rash—Fluorouracil—urinary bladder cancer	0.000419	0.0023	CcSEcCtD
Fluticasone furoate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000419	0.0023	CcSEcCtD
Fluticasone furoate—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000418	0.0023	CcSEcCtD
Fluticasone furoate—Headache—Fluorouracil—urinary bladder cancer	0.000416	0.00229	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000414	0.00227	CcSEcCtD
Fluticasone furoate—Immune system disorder—Epirubicin—urinary bladder cancer	0.000411	0.00226	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00041	0.00225	CcSEcCtD
Fluticasone furoate—Back pain—Methotrexate—urinary bladder cancer	0.00041	0.00225	CcSEcCtD
Fluticasone furoate—Visual impairment—Doxorubicin—urinary bladder cancer	0.000406	0.00223	CcSEcCtD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.000403	0.00853	CbGpPWpGaD
Fluticasone furoate—Nausea—Gemcitabine—urinary bladder cancer	0.000401	0.0022	CcSEcCtD
Fluticasone furoate—Rash—Cisplatin—urinary bladder cancer	0.000397	0.00218	CcSEcCtD
Fluticasone furoate—Dermatitis—Cisplatin—urinary bladder cancer	0.000397	0.00218	CcSEcCtD
Fluticasone furoate—Diarrhoea—Etoposide—urinary bladder cancer	0.000395	0.00217	CcSEcCtD
Fluticasone furoate—Nausea—Fluorouracil—urinary bladder cancer	0.000395	0.00217	CcSEcCtD
Fluticasone furoate—Eye disorder—Doxorubicin—urinary bladder cancer	0.000394	0.00216	CcSEcCtD
Fluticasone furoate—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000391	0.00827	CbGpPWpGaD
Fluticasone furoate—Back pain—Epirubicin—urinary bladder cancer	0.000383	0.0021	CcSEcCtD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—TNF—urinary bladder cancer	0.000383	0.0081	CbGpPWpGaD
Fluticasone furoate—Dizziness—Etoposide—urinary bladder cancer	0.000382	0.00209	CcSEcCtD
Fluticasone furoate—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000381	0.00209	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00038	0.00208	CcSEcCtD
Fluticasone furoate—Nausea—Cisplatin—urinary bladder cancer	0.000374	0.00205	CcSEcCtD
Fluticasone furoate—Cough—Methotrexate—urinary bladder cancer	0.00037	0.00203	CcSEcCtD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000368	0.00779	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.000368	0.00778	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000367	0.00776	CbGpPWpGaD
Fluticasone furoate—Agitation—Epirubicin—urinary bladder cancer	0.000364	0.002	CcSEcCtD
Fluticasone furoate—Rash—Etoposide—urinary bladder cancer	0.000364	0.002	CcSEcCtD
Fluticasone furoate—Dermatitis—Etoposide—urinary bladder cancer	0.000364	0.002	CcSEcCtD
Fluticasone furoate—Headache—Etoposide—urinary bladder cancer	0.000362	0.00198	CcSEcCtD
Fluticasone furoate—Back pain—Doxorubicin—urinary bladder cancer	0.000355	0.00195	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.000355	0.0075	CbGpPWpGaD
Fluticasone furoate—Palpitations—Epirubicin—urinary bladder cancer	0.00035	0.00192	CcSEcCtD
Fluticasone furoate—Cough—Epirubicin—urinary bladder cancer	0.000346	0.0019	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000346	0.0019	CcSEcCtD
Fluticasone furoate—Infection—Methotrexate—urinary bladder cancer	0.000343	0.00189	CcSEcCtD
Fluticasone furoate—Nausea—Etoposide—urinary bladder cancer	0.000343	0.00188	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.000343	0.00725	CbGpPWpGaD
Fluticasone furoate—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000339	0.00186	CcSEcCtD
Fluticasone furoate—ABCB1—lymph node—urinary bladder cancer	0.000338	0.0117	CbGeAlD
Fluticasone furoate—Agitation—Doxorubicin—urinary bladder cancer	0.000337	0.00185	CcSEcCtD
Fluticasone furoate—NR3C1—Circadian Clock—CREBBP—urinary bladder cancer	0.000333	0.00704	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000333	0.00704	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.00033	0.00698	CbGpPWpGaD
Fluticasone furoate—Palpitations—Doxorubicin—urinary bladder cancer	0.000324	0.00178	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000324	0.00178	CcSEcCtD
Fluticasone furoate—Infection—Epirubicin—urinary bladder cancer	0.000321	0.00176	CcSEcCtD
Fluticasone furoate—Cough—Doxorubicin—urinary bladder cancer	0.00032	0.00176	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000317	0.00174	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.000313	0.00662	CbGpPWpGaD
Fluticasone furoate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.000311	0.00658	CbGpPWpGaD
Fluticasone furoate—Dyspnoea—Methotrexate—urinary bladder cancer	0.000308	0.00169	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000299	0.00164	CcSEcCtD
Fluticasone furoate—Infection—Doxorubicin—urinary bladder cancer	0.000297	0.00163	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000294	0.00161	CcSEcCtD
Fluticasone furoate—Dyspnoea—Epirubicin—urinary bladder cancer	0.000288	0.00158	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.00028	0.00592	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.000279	0.00589	CbGpPWpGaD
Fluticasone furoate—Urticaria—Methotrexate—urinary bladder cancer	0.000275	0.00151	CcSEcCtD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000273	0.00578	CbGpPWpGaD
Fluticasone furoate—Body temperature increased—Methotrexate—urinary bladder cancer	0.000273	0.0015	CcSEcCtD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000272	0.00575	CbGpPWpGaD
Fluticasone furoate—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000267	0.00146	CcSEcCtD
Fluticasone furoate—Urticaria—Epirubicin—urinary bladder cancer	0.000257	0.00141	CcSEcCtD
Fluticasone furoate—Body temperature increased—Epirubicin—urinary bladder cancer	0.000256	0.0014	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000255	0.0014	CcSEcCtD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.00025	0.0053	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000247	0.00523	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000244	0.00516	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—NCOR1—urinary bladder cancer	0.000243	0.00514	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—urinary bladder cancer	0.000242	0.00511	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.00024	0.00508	CbGpPWpGaD
Fluticasone furoate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000238	0.00131	CcSEcCtD
Fluticasone furoate—Urticaria—Doxorubicin—urinary bladder cancer	0.000238	0.00131	CcSEcCtD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000237	0.00502	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000237	0.00502	CbGpPWpGaD
Fluticasone furoate—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000237	0.0013	CcSEcCtD
Fluticasone furoate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000237	0.0013	CcSEcCtD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000234	0.00495	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000233	0.00494	CbGpPWpGaD
Fluticasone furoate—Dizziness—Methotrexate—urinary bladder cancer	0.000229	0.00125	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000227	0.0048	CbGpPWpGaD
Fluticasone furoate—NR3C1—Circadian Clock—EP300—urinary bladder cancer	0.000227	0.00479	CbGpPWpGaD
Fluticasone furoate—Diarrhoea—Epirubicin—urinary bladder cancer	0.000221	0.00121	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000221	0.00121	CcSEcCtD
Fluticasone furoate—Rash—Methotrexate—urinary bladder cancer	0.000218	0.0012	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000218	0.00461	CbGpPWpGaD
Fluticasone furoate—Dermatitis—Methotrexate—urinary bladder cancer	0.000218	0.0012	CcSEcCtD
Fluticasone furoate—NR3C1—Adipogenesis—FAS—urinary bladder cancer	0.000218	0.00461	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000217	0.00459	CbGpPWpGaD
Fluticasone furoate—Headache—Methotrexate—urinary bladder cancer	0.000217	0.00119	CcSEcCtD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000214	0.00453	CbGpPWpGaD
Fluticasone furoate—Dizziness—Epirubicin—urinary bladder cancer	0.000214	0.00117	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000208	0.0044	CbGpPWpGaD
Fluticasone furoate—Nausea—Methotrexate—urinary bladder cancer	0.000205	0.00113	CcSEcCtD
Fluticasone furoate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000205	0.00112	CcSEcCtD
Fluticasone furoate—Rash—Epirubicin—urinary bladder cancer	0.000204	0.00112	CcSEcCtD
Fluticasone furoate—Dermatitis—Epirubicin—urinary bladder cancer	0.000204	0.00112	CcSEcCtD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000204	0.00431	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000203	0.00429	CbGpPWpGaD
Fluticasone furoate—Headache—Epirubicin—urinary bladder cancer	0.000203	0.00111	CcSEcCtD
Fluticasone furoate—Dizziness—Doxorubicin—urinary bladder cancer	0.000198	0.00109	CcSEcCtD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000198	0.00418	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000197	0.00417	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000196	0.00414	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000196	0.00414	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000193	0.00408	CbGpPWpGaD
Fluticasone furoate—Nausea—Epirubicin—urinary bladder cancer	0.000192	0.00105	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.000192	0.00406	CbGpPWpGaD
Fluticasone furoate—Rash—Doxorubicin—urinary bladder cancer	0.000189	0.00104	CcSEcCtD
Fluticasone furoate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000189	0.00104	CcSEcCtD
Fluticasone furoate—Headache—Doxorubicin—urinary bladder cancer	0.000188	0.00103	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000187	0.00395	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.000183	0.00388	CbGpPWpGaD
Fluticasone furoate—Nausea—Doxorubicin—urinary bladder cancer	0.000178	0.000976	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000175	0.0037	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000174	0.00369	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—PPARG—urinary bladder cancer	0.000174	0.00368	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.000173	0.00366	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000168	0.00356	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—RB1—urinary bladder cancer	0.000167	0.00352	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000166	0.00352	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IGF1—urinary bladder cancer	0.000165	0.00349	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000165	0.00348	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000163	0.00344	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000155	0.00328	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000154	0.00327	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000154	0.00326	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000145	0.00306	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000145	0.00306	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000141	0.00298	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000134	0.00283	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.00013	0.00275	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000128	0.00271	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000124	0.00263	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	0.00012	0.00253	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	0.000118	0.00249	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000116	0.00246	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000115	0.00243	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000115	0.00243	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.000106	0.00225	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000105	0.00223	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000104	0.0022	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000102	0.00215	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.000102	0.00215	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000101	0.00213	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	9.88e-05	0.00209	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	9.84e-05	0.00208	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	9.7e-05	0.00205	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TNF—urinary bladder cancer	9.24e-05	0.00196	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	8.87e-05	0.00188	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	8.6e-05	0.00182	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.29e-05	0.00175	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	7.99e-05	0.00169	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	7.6e-05	0.00161	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.56e-05	0.0016	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	7.53e-05	0.00159	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	7.4e-05	0.00156	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.99e-05	0.00148	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	6.97e-05	0.00147	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	6.95e-05	0.00147	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.9e-05	0.00146	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.6e-05	0.0014	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTO2—urinary bladder cancer	6.59e-05	0.00139	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NAT1—urinary bladder cancer	6.59e-05	0.00139	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.52e-05	0.00138	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.43e-05	0.00136	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	6.35e-05	0.00134	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	6.34e-05	0.00134	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.34e-05	0.00134	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	6.1e-05	0.00129	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	6.03e-05	0.00128	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.6e-05	0.00119	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ESR2—urinary bladder cancer	5.53e-05	0.00117	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.53e-05	0.00117	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	5.43e-05	0.00115	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.41e-05	0.00114	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	5.13e-05	0.00108	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PRSS3—urinary bladder cancer	4.99e-05	0.00106	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.89e-05	0.00103	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.73e-05	0.001	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.72e-05	0.000997	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.5e-05	0.000951	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.37e-05	0.000925	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.28e-05	0.000906	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	4.27e-05	0.000903	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.06e-05	0.000859	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.06e-05	0.000859	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	4.01e-05	0.000849	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.99e-05	0.000845	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.92e-05	0.000829	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.83e-05	0.000811	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.71e-05	0.000786	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.65e-05	0.000772	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	3.62e-05	0.000766	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.62e-05	0.000766	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.61e-05	0.000764	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ESR1—urinary bladder cancer	3.35e-05	0.000709	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.34e-05	0.000707	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.22e-05	0.000681	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.16e-05	0.000668	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.12e-05	0.000659	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.08e-05	0.000651	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PPARG—urinary bladder cancer	3.06e-05	0.000647	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	2.94e-05	0.000622	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.89e-05	0.000611	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.89e-05	0.000611	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.8e-05	0.000592	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.62e-05	0.000555	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.46e-05	0.00052	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.33e-05	0.000492	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.22e-05	0.000471	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.94e-05	0.000411	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.92e-05	0.000406	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.8e-05	0.000382	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.78e-05	0.000377	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.78e-05	0.000377	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.78e-05	0.000376	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.78e-05	0.000376	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MYC—urinary bladder cancer	1.74e-05	0.000369	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.73e-05	0.000365	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.71e-05	0.000361	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.68e-05	0.000355	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.58e-05	0.000333	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.43e-05	0.000303	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.28e-05	0.00027	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.23e-05	0.00026	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.2e-05	0.000253	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.11e-05	0.000235	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.1e-05	0.000232	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.1e-05	0.000232	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.05e-05	0.000223	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.03e-05	0.000219	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	0.000213	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.71e-06	0.000205	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTEN—urinary bladder cancer	8.77e-06	0.000185	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—EP300—urinary bladder cancer	8.36e-06	0.000177	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.87e-06	0.000167	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.56e-06	0.00016	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.19e-06	0.000131	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.4e-06	0.000114	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.15e-06	0.000109	CbGpPWpGaD
